Headline News

Short-term exposure to hormone therapy started within 3 years of menopause was not associated with long-term cognitive impairment or benefit, according to data from the KEEPS Continuation study.

BOSTON — Genetic testing can play a positive role and help improve outcomes in managing immunodeficiencies, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

INDIANAPOLIS — High-energy visible light-filtering multifocal lenses reduced glare disability and discomfort without affecting color perception, according to research presented at Academy 2024.

SAN DIEGO — ChatGPT 4.0 partly avoided discriminatory decision-making for patients with kidney disease, but had gaps in diversity, equity and inclusion, data show.

New, positive topline data found icotrokinra to be effective for the treatment of moderate to severe plaque psoriasis in patients aged 12 years and older, Protagonist Therapeutics and Johnson & Johnson announced.

Data from a nationally representative web survey of fertility in the U.S. revealed that condom use declined following the COVID-19 pandemic, while other contraceptive use patterns remained stable.

NEW YORK — In this Healio Video Perspective from OSN New York, Karolinne M. Rocha, MD, PhD, discusses the management of extreme astigmatism.

The FDA has cleared an investigational new drug application for an epigenetic regulator to treat intractable pain due to idiopathic small fiber neuropathy, according to the manufacturer.

DALLAS — In this video, Nicholas A. Bedard, MD, discusses results that showed about 20% of patients with periprosthetic joint infections of the knee met eligibility criteria for one-stage exchange.

Primary care providers should discuss prostate cancer screening with eligible patients and work to dispel common misconceptions that keep men from getting screened, according to an expert.